Novel Ophthalmic Topical Formulation Targeting Molecular Pathogenesis Of Corneal Haze
Funder
National Health and Medical Research Council
Funding Amount
$296,090.00
Summary
Presently, no drugs are proven to cure corneal haze/scarring, major leading cause of global blindness. Haze is caused by eye trauma, infections or refractive laser surgeries. We aim to test a non toxic, novel ophthalmic topical formulation developed to act on molecular and cellular targets of haze formation. The successful completion of the study will determine formulation’s optimal dose, safety and efficacy for its future potential clinical use in reversing corneal scarring/haze without side ef ....Presently, no drugs are proven to cure corneal haze/scarring, major leading cause of global blindness. Haze is caused by eye trauma, infections or refractive laser surgeries. We aim to test a non toxic, novel ophthalmic topical formulation developed to act on molecular and cellular targets of haze formation. The successful completion of the study will determine formulation’s optimal dose, safety and efficacy for its future potential clinical use in reversing corneal scarring/haze without side effects.Read moreRead less
THE ROLE OF MONOCYTIC LINEAGE CELLS IN MODELS OF CORNEAL DISEASE
Funder
National Health and Medical Research Council
Funding Amount
$311,567.00
Summary
Vision relies on sharp, focused undistorted images passing through the cornea, the clear 'window' at the front of the eye. Corneal disease causes over 5 million cases of blindness worldwide. In patients who damage the delicate covering of the cornea, due to trauma or contact lens wear, there is an increased risk of infection that may lead to blindness. This project will study the ways in which immune cells in the cornea detect invasion by potential pathogens.
Development And Evaluation Of Teleophthalmic Systems For Screening Of Common Blinding Eye Diseases
Funder
National Health and Medical Research Council
Funding Amount
$263,918.00
Summary
Portable ophthalmic instruments will provide digital images for storage and telemetric transmission to a disease control centre. We will be assessing and developing new portable ophthalmic imaging instruments, and validating them for common blinding eye conditions. The aim is to assess the ability of various health personal to document glaucoma, diabetic retinopathy, active trachoma, corneal scarring and cataract in rural screenings using digital imaging technology. A network of ophthalmologists ....Portable ophthalmic instruments will provide digital images for storage and telemetric transmission to a disease control centre. We will be assessing and developing new portable ophthalmic imaging instruments, and validating them for common blinding eye conditions. The aim is to assess the ability of various health personal to document glaucoma, diabetic retinopathy, active trachoma, corneal scarring and cataract in rural screenings using digital imaging technology. A network of ophthalmologists, health department personnel and aboriginal health workers in Western Australia will be involved. The project will also examine the quality of images obtained by health workers with various levels of skills and compare this with conventional photographs currently obtained by the screening network. Finally, the project will demonstrate practicality of the large scale storage of digital images of patient eyes. Preliminary evaluations have been performed on our teleophthalmology system using different portable instruments namely a handheld fundus camera, slit-lamp and indirect ophthalmoscope. We have also tested our teleophthalmology system at the Dr. Soetomo Hospital (Airlangga University) in Surabaya, Indonesia. Images captured using the handheld fundus camera were successfully transmitted to Lions Eye Institute through satellite, mobile and Internet lines. This pilot project has been sponsored by the Western Australian Department of Trade and Commerce and Telstra.Read moreRead less
A ROBOTIC MICRO DRAINAGE SURGERY FOR GLAUCOMA (A BIOLOGICAL MICROFISTULA AND IMPLANTATION METHOD AND APPARATUS)
Funder
National Health and Medical Research Council
Funding Amount
$441,020.00
Summary
Glaucoma is a major cause of blindness in our community. We are developing a new surgical procedure to treat glaucoma. The technique is based on the implantation of a tiny drainage tube inside the eye. This allows the eye's natural fluid to escape at the required rate. Insufficient drainage, or over production of fluid in the eye's of glaucoma patients is responsible for the high pressures inside the eye that characterise this disease. A simple, safe, and reliable surgical procedure to lower int ....Glaucoma is a major cause of blindness in our community. We are developing a new surgical procedure to treat glaucoma. The technique is based on the implantation of a tiny drainage tube inside the eye. This allows the eye's natural fluid to escape at the required rate. Insufficient drainage, or over production of fluid in the eye's of glaucoma patients is responsible for the high pressures inside the eye that characterise this disease. A simple, safe, and reliable surgical procedure to lower intraocular pressure would be a major benefit to the almost 67 million glaucoma patients worldwide, and would relieve the current need for lifelong medication.Read moreRead less
Toxoplasma Gondii Infection Of Human Retinal Pigment Epithelium
Funder
National Health and Medical Research Council
Funding Amount
$460,668.00
Summary
Ocular toxoplasmosis is a vision-threatening parasitic eye infection that is common in Australia and worldwide. No treatment cures the disease. This work will characterize cellular and molecular events occuring in the eye during an infection, which is an important first step toward the development of more effective treatments for patients with the condition.
Development Of A Novel Bioengineered Tissue Construct For Repairing The Eye.
Funder
National Health and Medical Research Council
Funding Amount
$335,817.00
Summary
Corneal diseases are often treated using donor tissue transplants. Nevertheless, donor tissue is unsuitable for treating the peripheral or limbal margin of the cornea. We have therefore developed a way to transplant sheets of limbal tissue (epithelium) grown in the laboratory from a patient's own cells, but this tissue lacks a foundation of connective tissue that we believe is essential for sustained healing. Thus, our aim is to develop a novel limbal transplant which contains both layers.